Zantac 150mg tablets

País: Regne Unit

Idioma: anglès

Font: MHRA (Medicines & Healthcare Products Regulatory Agency)

ingredients actius:

Ranitidine hydrochloride

Disponible des:

Dowelhurst Ltd

Codi ATC:

A02BA02

Designació comuna internacional (DCI):

Ranitidine hydrochloride

Dosis:

150mg

formulario farmacéutico:

Oral tablet

Vía de administración:

Oral

clase:

No Controlled Drug Status

tipo de receta:

Valid as a prescribable product

Resumen del producto:

BNF: 01030100

Informació per a l'usuari

Reason for Update: Type II to update in line with PSUSA -erlotinib and
Minor amendments
Market: UK
Agency Approval Date:
Text Date: 16/10/2019
Text Issue and Draft No.: Issue 09 Draft 01
LOGO GSK
PACKAGE LEAFLET: INFORMATION FOR THE USER
ZANTAC EFFERVESCENT TABLETS 150 MG AND 300 MG
RANITIDINE HYDROCHLORIDE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It
may harm them, even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes
any possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1
What Zantac is and what it is used for
2
What you need to know before you take Zantac
3
How to take Zantac Effervescent Tablets
4
Possible side effects
5
How to store Zantac
6
Contents of the pack and other information
1
WHAT ZANTAC IS AND WHAT IT IS USED FOR
Zantac contains a medicine called ranitidine. This belongs to a group
of medicines
called H
2
-receptor antagonists. It lowers the amount of acid in your stomach.
For adults (including the elderly) Zantac is used to:
•
heal and stop ulcers in the stomach, or the part of the gut it empties
into (the
duodenum)
•
help clear up infection in your stomach, when taken with antibiotic
medicines
(medicines taken to treat germs)
•
stop stomach ulcers when they are a side effect of some medicines
•
stop ulcers from bleeding
•
improve problems caused by acid in the food pipe (oesophagus) or too
much acid
in the stomach. Both of these can cause pain or discomfort sometimes
known as
‘indigestion’, ‘dyspepsia’ or ‘heartburn’
•
stop acid coming up from the stomach while under anaesthetic during an
operation.
For children (3 to 18 years) Zantac is used to:
•
heal u

Fitxa tècnica

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Zantac Tablets 150 mg
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains ranitidine 150 mg (as the hydrochloride).
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Adults
Duodenal ulcer and benign gastric ulcer, including that associated
with non-
steroidal anti-inflammatory agents.
Prevention of non-steroidal anti-inflammatory drug (NSAID) (including
aspirin) associated duodenal ulcers, especially in patients with a
history of
peptic ulcer disease.
Treatment of duodenal ulcers associated with _Helicobacter pylori_
infection.
Post-operative ulcer.
Oesophageal reflux disease including long term management of healed
oesophagitis.
Symptomatic relief in gastro-oesophageal reflux disease.
Zollinger-Ellison Syndrome.
Chronic episodic dyspepsia, characterised by pain (epigastric or
retrosternal)
which is related to meals or disturbs sleep but not associated with
the above
conditions.
Prophylaxis of gastrointestinal haemorrhage from stress ulceration in
seriously
ill patients
Prophylaxis of recurrent haemorrhage with bleeding peptic ulcers.
Before general anaesthesia in patients at risk of acid aspiration
(Mendelson's
syndrome), particularly obstetric patients during labour.
For appropriate cases, Zantac injection is also available (see
separate SPC).
Children (3 to 18 years)
Short term treatment of peptic ulcer
Treatment of gastro-oesophageal reflux, including reflux oesophagitis
and
symptomatic relief of gastro-oesophageal reflux disease.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults (including the elderly)
Usual dosage is 150 mg twice daily, taken in the morning and evening.
Duodenal ulcer, gastric ulcer:
The standard dosage regimen is 150 mg twice daily or 300 mg at night.
It is
not necessary to time the dose in relation to meals.
In most cases of duodenal ulcer, benign gastric ulcer and
post-operative ulcer,
healing occurs within 4 weeks. Healin